Vault-13

Puissance Capital Management LP

NEW YORK, NY · CIK 1658437 · 13F filing filed 2020-11-12

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$17.3m reported value -26.0% vs Q2 2020
5positions
100.0%in top 10
2 new 0 added 0 reduced 1 sold out vs Q2 2020

Holdings, Q3 2020

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BELLEROPHON THERAPEUTICS INC COM NEW BLPH BLPH 1,153,846 $11.7m67.74% 67.74% UnchangedShares held: Q4 2019 0, Q1 2020 553.2k, Q2 2020 1.2m, Q3 2020 1.2m
2 EKSO BIONICS HLDGS INC COM COM 774,400 $3.7m21.21% 21.21% UnchangedShares held: Q4 2019 0, Q1 2020 774.4k, Q2 2020 774.4k, Q3 2020 774.4k
3 SCYNEXIS INC COM NEW COM NEW 311,143 $1.4m7.91% 7.91% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 0, Q3 2020 311.1k
4 KADMON HLDGS INC COM KDMN KDMN 100,184 $393.0k2.27% 2.27% NewShares held: Q4 2019 0, Q1 2020 30.0k, Q2 2020 0, Q3 2020 100.2k
5 CORVUS PHARMACEUTICALS INC COM CRVS CRVS 38,010 $152.0k0.88% 0.88% UnchangedShares held: Q4 2019 38.0k, Q1 2020 38.0k, Q2 2020 38.0k, Q3 2020 38.0k

Sold out since Q2 2020

SecurityTickerShares held beforeValue then
SCYNEXIS INC 3,111,436 $2.3m3.1m shares